MDMA-related presentations to the emergency departments of the European Drug Emergencies Network plus (Euro-DEN Plus) over the four-year period 2014–2017

References

• European Monitoring Centre for Drugs and Drug Addiction (Internet). European Drug Report (Trends and Development) 2019. Lisbon; 2019. Available from: http://www.emcdda.europa.eu/publications/edr/trends-developments/2019
   Google Scholar
• European Monitoring Centre for Drugs and Drug Addiction (Internet). EU Drug Markets Report 2019. EMCDDA, Europol, Lisbon; 2019. Available from: http://www.emcdda.europa.eu/publications/joint-publications/eu-drug-markets-report-2019
   Google Scholar
• European Monitoring Centre for Drugs and Drug Addiction (Internet). Recent changes in Europe’s MDMA/ecstasy market: results from an EMCDDA trendspotter study. EMCDDA, Lisbon; 2016. Available from: http://www.emcdda.europa.eu/publications/rapid-communications/2016/mdma
   Google Scholar
• Horyniak D, Degenhardt L, Smit de V, et al. Pattern and characteristics of ecstasy and related drug (ERD) presentations at two hospital emergency departments, Melbourne, Australia, 2008–2010. Emerg Med J. 2014;31:317–322.
   PubMed Web of Science ®Google Scholar
• Liechti ME, Kunz I, Kupferschmidt H. Acute medical problems due to ecstasy use. Case-series of emergency department visits. Swiss Med Wkly. 2005;135:652–657.
   PubMed Web of Science ®Google Scholar
• Rogers G, Elston J, Garside R, et al. The harmful health effects of recreational ecstasy: a systematic review of observational evidence. Health Technol Assess. 2009;13:1–354.
   Web of Science ®Google Scholar
• Wood DM, Heyerdahl F, Yates CB, et al. The European Drug Emergencies Network (Euro-DEN). Clin Toxicol. 2014;52:239–241.
   PubMed Web of Science ®Google Scholar
• Heyerdahl F, Hovda KE, Giraudon I, et al. Current European data collection on emergency department presentations with acute recreational drug toxicity: gaps and national variations. Clin Toxicol. 2014;52:1005–1012.
   PubMed Web of Science ®Google Scholar
• Williams H, Dratcu L, Taylor R, et al. "Saturday night fever": ecstasy related problems in a London accident and emergency department. J Accid Emerg Med. 1998;15:322–326.
   PubMedGoogle Scholar
• Sanjurjo E, Nogué S, Miró O, et al. Analysis of patients attended in an emergency department due to ecstasy consumption. Med Clin. 2004;123:90–92.
   PubMed Web of Science ®Google Scholar
• Liakoni E, Yates C, Dines AM, et al.; Euro-DEN Plus Research Group. Acute recreational drug toxicity: comparison of self-reports and results of immunoassay and additional analytical methods in a multicenter European case series. Medicine. 2018;97:e9784.
   PubMed Web of Science ®Google Scholar
• European Monitoring Centre for Drugs and Drug Addiction (Internet). Drug-related hospital emergency presentations in Europe: update from the Euro-DEN Plus expert network. Lisbon; 2020. Available from: http://www.emcdda.europa.eu/publications/technical-reports/drug-related-hospital-emergency-presentations-in-europe
   Google Scholar
• European Monitoring Centre for Drugs and Drug Addiction (Internet). Technical Report, Estimating the size of the main illicit retail drug markets in Europe: an update 2019. Available from: http://www.emcdda.europa.eu/system/files/publications/12174/TD0219965ENN.pdf
   Google Scholar
• Schwartz RH, Miller NS. MDMA (ecstasy) and the rave: a review. Pediatrics. 1997;100:705–708.
   PubMed Web of Science ®Google Scholar
• EMCCDA 2015. ° European drug report 2015: trends and developments. Luxembourg: Publications Office of the European Union. Available from: http://www.emcdda.europa.eu/publications/edr/trends-developments/2015
   Google Scholar
• Barrett SP, Gross SR, Garand I, et al. Patterns of simultaneous polysubstance use in Canadian rave attendees. Subst Use Misuse. 2005;40:1525–1537.
   PubMed Web of Science ®Google Scholar
• Parrott AC, Milani RM, Gouzoulis-Mayfrank E, et al. Cannabis and Ecstasy/MDMA (3,4-methylenedioxymethamphetamine): an analysis of their neuropsychobiological interactions in recreational users. J Neural Transm. 2007;114:959–968.
   PubMed Web of Science ®Google Scholar
• Green AR, Mechan AO, Elliott JM, et al. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). Pharmacol Rev. 2003;55:463–508.
   PubMed Web of Science ®Google Scholar
• Dumont GJ, Verkes RJ. A review of acute effects of 3,4-methylenedioxymethamphetamine in healthy volunteers. J Psychopharmacol. 2006;20:176–187.
   PubMed Web of Science ®Google Scholar
• Curran HV, Travill RA. Mood and cognitive effects of +/-3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'): week-end 'high' followed by mid-week low. Addiction. 1997;92:821–831.
   PubMed Web of Science ®Google Scholar
• Meyer JS. 3,4-methylenedioxymethamphetamine (MDMA): current perspectives. Subst Abuse Rehabil. 2013;21:83–99.
   Google Scholar
• Baylen CA, Rosenberg H. A review of the acute subjective effects of MDMA/ecstasy. Addiction. 2006;101:933–947.
   PubMed Web of Science ®Google Scholar
• Bearn J, O'Brien M. "Addicted to Euphoria": The History, Clinical Presentation, and Management of Party Drug Misuse. Int Rev Neurobiol. 2015;120:205–233.
   PubMed Web of Science ®Google Scholar
• Halpern P, Moskovich J, Avrahami B, et al. Morbidity associated with MDMA (ecstasy) abuse: a survey of emergency department admissions. Hum Exp Toxicol. 2011;30:259–266.
   PubMed Web of Science ®Google Scholar
• Armenian P, Mamantov TM, Tsutaoka BT, et al. Multiple MDMA (Ecstasy) overdoses at a rave event: a case series. J Intensive Care Med. 2013;28:252–258.
   PubMedGoogle Scholar
• Davies N, English W, Grundlingh J. MDMA toxicity: management of acute and life-threatening presentations. Br J Nurs. 2018;27:616–622.
   PubMedGoogle Scholar
• Bauman JL, DiDomenico RJ. Cocaine-induced channelopathies: emerging evidence on the multiple mechanisms of sudden death. J Cardiovasc Pharmacol Ther. 2002;7:195–202.
   PubMedGoogle Scholar
• Liaudet L, Calderari B, Pacher P. Pathophysiological mechanisms of catecholamine and cocaine-mediated cardiotoxicity. Heart Fail Rev. 2014;19:815–824.
   PubMed Web of Science ®Google Scholar
• Thompson JP. Acute effects of drugs of abuse. Clin Med. 2003;3:123–126.
   PubMed Web of Science ®Google Scholar